搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
42 分钟
Exclusive-Thousands turn to Wegovy copies each month as FDA considers shortage status
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
Pharmaceutical Technology
3 小时
Exploring drug shortages in european markets: the causes, analysis, and response
Since 2023, the pharmaceutical industry operating in Europe has faced an unprecedented challenge related to drug shortages.
The UK
5 小时
Biotech company to sell its genetics operation in deal worth up to £260m
Sheffield-headquartered aquaculture biotechnology company, Benchmark, has agreed to sell its genetics business area to Novo ...
FiercePharma
6 小时
Pfizer led industrywide sales surge in Q3 after several quarters of dominance by Eli Lilly ...
After six straight quarters in which Eli Lilly or Novo Nordisk achieved the highest year-over-year revenue growth among the ...
6 小时
LONDON BRIEFING: Anglo American sells coal mines for USD3.8 billion
In early UK corporate news, miner Anglo American and fish farming company Benchmark Holdings announced disposals. DIY retail chain operator Kingfisher trimmed the top of its profit outlook range, as ...
10 小时
Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial?
Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the ...
14 小时
Wait, Why Is Novo Selling Weight Loss Drugs for So Cheap in China?
Pharmaceutical company Novo Nordisk has launched its mega-popular weight-loss drug Wegovy in China — but for a tiny fraction ...
1 天
Are Hedge Funds Betting Big on Novo Nordisk (NVO)’s Diabetes and Chronic Disease Care?
We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...
2 天
on MSN
Ozempic’s maker wants the US government to ban cheaper versions of the high-priced $969 ...
Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...
MedPage Today
2 天
CGM Uptake Very Low for Vulnerable Diabetes Populations
Uptake of continuous glucose monitoring (CGM) was relatively low among vulnerable diabetes patients in the largest national ...
2 天
Social conservatism in the (second) Trump era
Social conservatives have not found much of a home in DONALD TRUMP ’s Cabinet — at least not in the vein of Focus on the ...
2 天
on MSN
Novo Holdings set to win EU nod for $16.5 billion Catalent deal, source says
Novo Holdings is set to gain unconditional EU antitrust approval for its planned $16.5 billion takeover of U.S. contract drug ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈